Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables

by Thierry Berghmans, Marianne Paesmans, Jean-Paul Sculier
Published 2011-05-01

Correction: Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, r...

by Leila Paquier, Patricia Barlow, Marianne Paesmans, Serge Rozenberg
Published 2020-03-01

Do recent immigrants have similar obstetrical care and perinatal complications as long-term residents? A retrospective exploratory cohort study in Brussels

by Leila Paquier, Patricia Barlow, Marianne Paesmans, Serge Rozenberg
Published 2020-03-01

Correction: The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption

by Leila Paquier, Patricia Barlow, Marianne Paesmans, Serge Rozenberg
Published 2020-03-01

Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity

by Michel Moreau, Ahmad Awada, Marianne Paesmans, Dan Engelman, Antonia Lepida, Yasmine Zaouak
Published 2020-05-01

Single High Intensity Focused Ultrasound Session as a Whole Gland Primary Treatment for Clinically Localized Prostate Cancer: 10-Year Outcomes

by Ksenija Limani, Fouad Aoun, Serge Holz, Marianne Paesmans, Alexandre Peltier, Roland van Velthoven
Published 2014-01-01

MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men

by Alexandre Peltier, Fouad Aoun, Marc Lemort, Félix Kwizera, Marianne Paesmans, Roland Van Velthoven
Published 2015-01-01

Are intensive cares worthwhile for breast cancer patients: the experience of an oncological ICU.

by Virginie Destrebecq, Thierry Berghmans, Ameye Lieveke, Marianne Paesmans, Jean-Paul Sculier, Anne-Pascale Meert
Published 2016-10-01

Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rati...

by Bernardo Leon Rapoport, Matti Aapro, Marianne Paesmans, Ronwyn van Eeden, Teresa Smit, Andriy Krendyukov, Jean Klastersky
Published 2018-09-01

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence

by José R. Rossari, Otto Metzger-Filho, Marianne Paesmans, Kamal S. Saini, Alessandra Gennari, Evandro de Azambuja, Martine Piccart-Gebhart
Published 2012-01-01

Assessment of self-reported fractures: data from the FRISBEE cohort

by Felicia Baleanu, Michel Moreau, Virginie Kinnard, Laura Iconaru, Rafik Karmali, Serge Rozenberg, Michel Rubinstein, Marianne Paesmans, Pierre Bergmann, Jean-Jacques Body
Published 2020-10-01

Risk factors for imminent fractures: A substudy of the Frisbee cohort

by Laura Iconaru, Michel Moreau, Felicia Baleanu, Virginie Kinnard, Alexia Charles, Aude Mugisha, Murielle Surquin, Florence Benoit, Rafik Karmali, Marianne Paesmans, Jean-Jacques Body, Pierre Bergmann
Published 2021-04-01

Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?

by Yves Libert, Stéphanie Dubruille, Cindy Borghgraef, Anne-Marie Etienne, Isabelle Merckaert, Marianne Paesmans, Christine Reynaert, Myriam Roos, Jean-Louis Slachmuylder, Sandrine Vandenbossche, Dominique Bron, Darius Razavi
Published 2016-01-01

Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS).

by Jérôme Toussaint, Virginie Durbecq, Sevilay Altintas, Valérie Doriath, Ghizlane Rouas, Marianne Paesmans, Philippe Bedard, Benjamin Haibe-Kains, Wiebren A Tjalma, Denis Larsimont, Martine Piccart, Christos Sotiriou
Published 2010-01-01

Osteoporosis treatment gap in the FRISBEE cohort

by Laura Iconaru, Celeste Smeys, Felicia Baleanu, Virginie Kinnard, Michel Moreau, Silvie Cappelle, Murielle Surquin, Michel Rubinstein, Serge Rozemberg, Marianne Paesmans, Rafik Karmali, Pierre Bergmann, Jean-Jacques Body
Published 2020-10-01

CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial

by Françoise Rothé, Marion Maetens, Ghizlane Rouas, Marianne Paesmans, Marc Van den Eynde, Jean-Luc Van Laethem, Philippe Vergauwe, Guido Deboever, Yacine Bareche, Caroline Vandeputte, Michail Ignatiadis, Alain Hendlisz
Published 2019-04-01

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study

by Thierry Berghmans, Jean-Jacques Lafitte, Arnaud Scherpereel, Lieveke Ameye, Marianne Paesmans, Anne-Pascale Meert, Benoit Colinet, Christian Tulippe, Luc Willems, Nathalie Leclercq, Jean-Paul Sculier, for the European Lung Cancer Working Party
Published 2015-10-01

Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub‐Study of the FRISBEE Cohort

by Felicia Baleanu, Laura Iconaru, Alexia Charles, Virginie Kinnard, Jean‐François Fils, Michel Moreau, Rafik Karmali, Murielle Surquin, Florence Benoit, Aude Mugisha, Marianne Paesmans, Michaël R Laurent, Pierre Bergmann, Jean‐Jacques Body
Published 2021-09-01

Independent external validation of FRAX® and Garvan fracture risk calculators: A sub-study of the FRISBEE cohort

by Felicia Baleanu, Alexia Charles, Laura Iconaru, Virginie Kinnard, Jean-François Fils, Michel Moreau, Rafik Karmali, Murielle Surquin, Florence Benoit, Aude Mugisha, Marianne Paesmans, Michaël R. Laurent, Pierre Bergmann, Jean-Jacques Body
Published 2021-04-01

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials

by Nicolas Charette, Caroline Vandeputte, Lieveke Ameye, Camille Van Bogaert, Jonathan Krygier, Thomas Guiot, Amélie Deleporte, Thierry Delaunoit, Karen Geboes, Jean-Luc Van Laethem, Marc Peeters, Gauthier Demolin, Stéphane Holbrechts, Patrick Flamen, Marianne Paesmans, Alain Hendlisz
Published 2019-02-01